Literature DB >> 16175033

Nutrition and infection in the intensive care unit: what does the evidence show?

Rupinder Dhaliwal1, Daren K Heyland.   

Abstract

PURPOSE OF REVIEW: Nutrition support when applied appropriately, can improve clinical outcomes, particularly the incidence of infections. The Canadian Clinical Practice Guidelines for Nutrition Support, published in October 2003, summarized the evidence on nutrition support in the critically ill patient and provided recommendations aimed at maximizing the benefits of nutrition support while minimizing the risks. The purpose of this review is to highlight recent advances in nutrition research in critically ill adult patients, particularly with respect to minimizing infection. The newly published data will be used to update the Canadian Clinical Practice Guidelines. RECENT
FINDINGS: Recent studies have confirmed that the use of enteral nutrition versus parenteral nutrition, early initiation of enteral nutrition, use of enteral and parenteral glutamine and intensive insulin therapy are all associated with reduced infectious morbidity in critically ill patients. A recent meta-analysis suggests that antioxidant supplementation is associated with no improvement in infectious complications, but an increase in survival. The recommendations from the Canadian Clinical Practice Guidelines for Nutrition Support have been updated based on the data from these recent trials.
SUMMARY: This review provides insights into the results of recent randomized trials on nutrition support in critically ill patients. The Canadian Clinical Practice Guidelines for nutrition support help intensive care unit clinicians to keep abreast of emerging evidence and the impact of nutrition support practices on outcomes such as infections.

Entities:  

Mesh:

Year:  2005        PMID: 16175033     DOI: 10.1097/01.ccx.0000176693.85260.cd

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  4 in total

Review 1.  Immune-modulating enteral formulations: optimum components, appropriate patients, and controversial use of arginine in sepsis.

Authors:  Minhao Zhou; Robert G Martindale
Journal:  Curr Gastroenterol Rep       Date:  2007-08

2.  Chylothorax after surgery on congenital heart disease in newborns and infants -risk factors and efficacy of MCT-diet.

Authors:  Eva S Biewer; Christoph Zürn; Raoul Arnold; Martin Glöckler; Jürgen Schulte-Mönting; Christian Schlensak; Sven Dittrich
Journal:  J Cardiothorac Surg       Date:  2010-12-13       Impact factor: 1.637

3.  Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study.

Authors:  Menghua Luo; Niloofar Bazargan; Daniel P Griffith; Concepción F Estívariz; Lorraine M Leader; Kirk A Easley; Nicole M Daignault; Li Hao; Jon B Meddings; John R Galloway; Jeffrey B Blumberg; Dean P Jones; Thomas R Ziegler
Journal:  Clin Nutr       Date:  2008-02-07       Impact factor: 7.324

4.  Assay of the multiple energy-producing pathways of mammalian cells.

Authors:  Barry R Bochner; Mark Siri; Richard H Huang; Shawn Noble; Xiang-He Lei; Paul A Clemons; Bridget K Wagner
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.